Recombinant Proteins
Modified or manipulated proteins encoded by recombinant DNA and suitable for a variety of purposes including the modification of gene sequences, mass protein production, and the manufacture of commercial products.
For Use With (Application)
- (2)
- (970)
- (1)
- (23,543)
- (5)
- (1)
- (1)
- (67)
- (219)
- (4,425)
- (23)
- (1)
- (4)
- (2)
- (13)
- (21,461)
- (3)
- (4)
- (3)
- (1)
- (2)
- (4)
- (14)
- (71)
- (2)
- (2)
- (2)
- (1)
- (3)
- (2)
- (1)
- (3)
- (4)
- (1)
- (1)
- (1)
- (3)
- (254)
- (22,606)
- (1)
- (1)
- (2)
- (1)
- (13)
- (26,166)
- (266)
- (32)
- (3)
- (708)
- (14)
- (2)
- (1)
- (8)
- (1)
- (5)
- (1)
- (108)
- (1)
- (3,782)
- (1,408)
- (3)
- (4)
- (2)
- (5)
- (1)
- (1)
- (1)
- (1)
- (14)
- (138)
- (48)
- (6)
- (17)
- (2)
- (1)
- (4)
- (81)
- (12)
- (2)
- (3)
- (80)
- (4)
- (113)
- (96)
- (19)
- (1)
- (1)
- (4)
- (1)
- (1,525)
- (2)
- (1)
- (3)
- (18)
- (48)
- (3)
- (1)
- (2)
- (9)
- (27)
- (2)
- (201)
- (1)
- (4)
- (1)
- (2)
- (114)
- (44)
- (2)
- (1)
- (1)
- (4)
- (1)
- (1)
- (3)
- (1)
- (23,710)
- (6)
- (3)
- (1)
- (1)
- (63)
- (6)
- (2)
- (7)
- (5)
- (1)
- (2)
- (1)
- (1)
- (6,728)
- (6)
- (4)
- (1)
- (3)
- (1)
- (3)
- (2)
- (13)
- (17)
- (1)
- (3)
- (3)
- (4)
- (25,926)
- (240)
- (1)
- (3)
Recombinant
- (286)
- (2)
- (61,756)
- (1)
Form
- (15)
- (1)
- (2)
- (45,218)
- (5,703)
- (245)
- (168)
- (56)
- (3,364)
Species
- (2)
- (1)
- (2)
- (1)
- (21)
- (559)
- (96)
- (2)
- (1)
- (1)
- (2)
- (1)
- (27)
- (1)
- (8)
- (15)
- (1)
- (72)
- (1)
- (1,050)
- (1)
- (3)
- (16)
- (1)
- (3)
- (1)
- (1)
- (1)
- (8)
- (1)
- (4)
- (1)
- (1)
- (26,022)
- (5)
- (1)
- (4)
- (582)
- (2)
- (1)
- (1)
- (3)
- (1)
- (1)
- (14)
- (32)
- (24)
- (1)
- (2)
- (16)
- (120)
- (9)
- (2)
- (1)
- (2)
- (2)
- (2)
- (23)
- (5)
- (3)
- (3)
- (2)
- (14)
- (23,574)
- (1)
- (48)
Conjugate
- (7)
- (1)
- (3)
- (18)
- (2)
- (62)
- (1)
- (4)
- (2)
- (9)
- (59)
- (1)
- (2)
- (3)
- (1)
- (391)
- (1)
- (3)
- (2)
- (1)
- (1)
- (1)
- (3)
- (2)
- (6)
- (19)
- (7)
- (2)
- (2)
- (3)
- (45)
- (1)
- (1)
- (1)
- (2)
- (5)
- (1)
- (1)
- (1)
- (1)
- (2)
- (8)
- (2)
- (3)
- (38,959)
- (1)
- (11)
Filtered Search Results
Products from some of our suppliers do not display in filtered search results. Please
clear all filters
to see these products.
Keyword Search:
Clear search
3,121
–
3,135
of
115,739
results
3,121
Novus Biologicals Recombinant Human Transthyretin/Prealbumin L55P Variant, Monomer Protein
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
| Purity or Quality Grade | >95%, by SDS-PAGE |
|---|---|
| Gene Alias | ATTR, HsT2651, PALBTBPA, Prealbumin, prealbumin, amyloidosis type I, thyroxine-binding prealbumin, transthyretin |
| Gene ID (Entrez) | 7276 |
| Formulation | PBS pH 7.4 |
| Gene Symbol | TTR |
| Research Category | Cancer |
| Storage Requirements | Store at -80C. Avoid freeze-thaw cycles. |
| For Use With (Application) | In vitro Assay,In vivo Assay,SDS-PAGE,Western Blot |
| Protein | Transthyretin/Prealbumin |
3,122
R&D Systems™ Recombinant Human LYPD6 Fc Chimera Protein
The Recombinant Human LYPD6 Fc Chimera Protein is derived from HEK293
3,123
| Accession Number | P60568.1 |
|---|---|
| Conjugate | Unconjugated |
| Gene Alias | aldesleukin, IL2, IL-2, IL-2lymphokine, interleukin 2, interleukin-2, involved in regulation of T-cell clonal expansion, Proleukin, T cell growth factor, T-cell growth factor, TCGF |
| Molecular Weight (g/mol) | M.W.-observed: 12-14 kDa, under reducing conditions., M.W.-theroretical: 15 kDa |
| Gene ID (Entrez) | 3558 |
| Formulation | Lyophilized from a 0.2 μm filtered solution in Sodium Acetate with Trehalose. |
| Reconstitution | Reconstitute the 10 μg size at 100 μg/mL in water. Reconstitute all the other sizes at 500 μg/mL in water. |
| Endotoxin Concentration | <0.20 EU per 1 μg of the protein by the LAL method. |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution. |
| For Use With (Application) | Bioactivity |
| Protein | IL-2 |
| Source | E. coli-derived human IL-2 protein Ala21-Thr153 (C145S) with and without an N-terminal Met Proprietary point mutations |
3,124
Novus Biologicals™ SRGN Protein
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Highly purified. Generating reliable and reproducible results.
3,125
Novus Biologicals™ NIT2 Protein
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Highly purified. Generating reliable and reproducible results.
| Regulatory Status | RUO |
|---|---|
| Purification Method | SDS-PAGE |
| Purity or Quality Grade | >95% |
| Conjugate | Unconjugated |
| Common Name | NIT2 |
| Molecular Weight (g/mol) | 33kDa |
| Formulation | Liquid. In 20mM Tris-HCl buffer (pH 8.0) containing 1mM DTT, 10% glycerol, 0.1M NaCl |
| Storage Requirements | Store at -80°C. Avoid freeze-thaw cycles. |
| Concentration | 1mg/mL |
| For Use With (Application) | SDS-PAGE |
3,126
R&D Systems™ Recombinant Human LAG-3 His-tag Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
3,127
R&D Systems™ Recombinant Human IL-17F (NS0-expressed) Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
| Conjugate | Unconjugated |
|---|---|
| Molecular Weight (g/mol) | 15.7 kDa (monomer) |
| Gene ID (Entrez) | 112744 |
3,128
| Purity or Quality Grade | >90% as determined by SDS-PAGE. |
|---|---|
| Conjugate | Unconjugated |
| pH Range | 7.4 |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 101.4 kDa |
| Common Name | SARS-CoV-2 Spike Protein S1 |
| Activity | Measured by its binding ability in a functional ELISA. Immobilized human ACE2 protein (His tag) at 2 μg/mL (100 μL/well) can bind SARS-CoV-2 (2019-nCoV) Spike Protein (S1, mFc Tag) (RP-88437), the EC50 of 2019-nCoV Spike Protein (S1, mFc Tag) is 90-240 ng/mL. |
| Endotoxin Concentration | <1.0 EU/μg |
| Storage Requirements | -20°C, Avoid Freeze/Thaw Cycles |
| Sequence | SARS-CoV-2 spike S1, amino acids Val16-Arg685 (Accession # YP_009724390.1) with a C-terminal mouse IgG1 Fc region |
| Concentration | 0.25 mg/mL |
| Expression System | HEK293 cells |
| For Use With (Application) | Control,ELISA Standard,Binding Assay |
| Name | SARS-CoV-2 Spike Protein S1 Fc Chimera |
| Regulatory Status | RUO |
| Purification Method | Purified |
| Gene Alias | Coronavirus; COVID; Covid 19; COVID19; COVID-19; SARS; SARS Coronavirus; SARS CoV; SARS CoV2; SARS CoV-2; SARS Spike Protein; SARS-CoV2; SARS-CoV-2 |
| Product Type | Protein |
| Formulation | PBS with 5% mannitol, 5% trehalose, 0.01% Tween 80 and no preservative; pH 7.4 |
| Protein Tag | Fc-tag |
| Recombinant | Recombinant |
3,129
| Purity or Quality Grade | >90% as determined by SDS-PAGE. |
|---|---|
| Conjugate | Unconjugated |
| pH Range | 7.5 |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 76.45 kDa |
| Common Name | SARS-CoV-2 Spike Protein S1 |
| Activity | Measured by its binding ability in a functional ELISA. Immobilized human ACE2 protein (Fc tag) at 2 μg/mL (100 μL/well) can bind SARS-CoV-2/2019-nCoV Spike Protein (S1 Subunit, His tag), the EC50 of SARS-CoV-2/2019-nCoV Spike Protein (S1 Subunit, His tag) is 300-700 ng/mL. |
| Endotoxin Concentration | <1.0 EU/μg |
| Storage Requirements | -20°C, Avoid Freeze/Thaw Cycles |
| Sequence | SARS-CoV-2 spike S1, amino acids Val16-Arg685 (Accession # YP_009724390.1) with a C-terminal His-tag |
| Expression System | Baculovirus |
| For Use With (Application) | Control,ELISA Standard,Binding Assay |
| Name | SARS-CoV-2 Spike Protein S1 His-tag |
| Regulatory Status | RUO |
| Purification Method | Purified |
| Gene Alias | Coronavirus; COVID; Covid 19; COVID19; COVID-19; SARS; SARS Coronavirus; SARS CoV; SARS CoV2; SARS CoV-2; SARS Spike Protein; SARS-CoV2; SARS-CoV-2 |
| Product Type | Protein |
| Formulation | 20mM PBS with 5% mannitol, 300mM NaCl, 5% trehalose, 0.01% Tween 80 and no preservative; pH 7.5 |
| Protein Tag | His-tag |
| Recombinant | Recombinant |
3,130
Novus Biologicals™ THTPA Protein
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Highly purified. Generating reliable and reproducible results.
| Regulatory Status | RUO |
|---|---|
| Purification Method | Protein |
| Purity or Quality Grade | >90% |
| Conjugate | Unconjugated |
| Common Name | THTPA |
| Molecular Weight (g/mol) | 27.7kDa |
| Formulation | In 20mM Tris-HCl buffer (pH 8.0) containing 10% glycerol 1mM DTT |
| Immunogen | MGSSHHHHHH SSGLVPRGSH MAQGLIEVER KFLPGPGTEE RLQELGGTLE YRVTFRDTYY DTPELSLMQA DHWLRRREDS GWELKCPGAA GVLGPHTEYK ELTAEPTIVA QLCKVLRADG LGAGDVAAVL GPLGLQEVAS FVTKRSAWKL VLLGADEEEP QLRVDLDTAD FGYAVGEVEA LVHEEAEVPT ALEKIHRLSS MLGVPAQETA PAKLIVYLQR FRPQDYQRLL EVNSSRERPQ ETEDPDHCLG |
| Storage Requirements | Store at -80°C. Avoid freeze-thaw cycles. |
| Concentration | 1.0mg/mL |
| For Use With (Application) | ELISA,SDS-PAGE |
| Source | Human |
3,131
R&D Systems™ Recombinant Human Neuronal Pentraxin 1 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
3,132
| Content And Storage | -20°Cor to +80°C if preferred |
|---|---|
| Purity or Quality Grade | >95% by SDS-PAGE under reducing conditions |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | SARS-CoV-2 Spike Protein RBD |
| Molecular Weight (g/mol) | 27 kDa |
| Sequence | SARS-CoV-2 Spike Protein (s-RBD) contains amino acids 330-524 of the SARS-CoV-2 Spike protein with a His-tag |
| Concentration | Conc. Not Determined |
| Expression System | E. coli |
| For Use With (Application) | Control,ELISA Standard,Binding Assay |
| Source | E. coli |
| Name | SARS-CoV-2 Spike Protein (RBD) (aa330-524), His Tag |
| Regulatory Status | RUO |
| Gene Alias | Coronavirus; COVID; Covid 19; COVID19; COVID-19; SARS; SARS Coronavirus; SARS CoV; SARS CoV2; SARS CoV-2; SARS Spike Protein; SARS-CoV2; SARS-CoV-2 |
| Formulation | PBS with no preservative |
| Protein Tag | His-tag |
| Recombinant | Recombinant |
3,133
Invitrogen™ SARS-COV-2 3CL Protease (aa1-306), His and Avi Tag Recombinant Protein
Recombinant Protein
Encompass Procurement Services
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Content And Storage | -80°C, Avoid Freeze/Thaw Cycles |
|---|---|
| Purity or Quality Grade | >95% by SDS-PAGE |
| Conjugate | Unconjugated |
| Form | Liquid |
| Common Name | SARS 3CL Protease |
| Molecular Weight (g/mol) | 36.9 kDa |
| Endotoxin Concentration | <1.0 EU/μg |
| Sequence | SARS-CoV-2 3CL Protease, amino acids Ser1-Gln306 with an initial Met and an N-terminal His-tag and Avi-tag |
| Concentration | 0.579 mg/mL |
| Expression System | E. coli |
| For Use With (Application) | Control,Bioactivity |
| Source | E. coli |
| Name | SARS-COV-2 3CL Protease (aa1-306), His and Avi Tag |
| Regulatory Status | RUO |
| Gene Alias | Coronavirus; COVID; COVID 19; COVID-19; SARS Coronavirus; SARS CoV; SARS CoV2; SARS-CoV-2 |
| Formulation | 20mM HEPES with 120mM NaCl, 10% glycerol, 2mM TCEP and no preservative; pH 7.4 |
| Protein Tag | His-tag, Avi-tag |
| Recombinant | Recombinant |
3,134
3,135
Invitrogen™ SARS-CoV-2 Nucleocapsid, His Tag Recombinant Protein
Recombinant Protein
Encompass Procurement Services
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Regulatory Status | RUO |
|---|---|
| Purity or Quality Grade | >95% by reducing SDS-PAGE |
| Conjugate | Unconjugated |
| Form | Liquid |
| Formulation | PBS with no preservative; pH 7.4 |
| Sequence | Full-length |
| For Use With (Application) | Control,ELISA,Western Blot |
| Source | E. coli |
| Name | SARS-CoV-2 Nucleocapsid, His Tag |
| Recombinant | Recombinant |